BSX vs ISRG
BSX and ISRG side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORPORATION | ISRGIntuitive Surgical, Inc. |
|---|---|---|
| Market cap | $63.59B | $133.26B |
| P/E (TTM) | 17.8 | 43.3 |
| P/B | 2.55 | 7.33 |
| P/S | 3.2x | 13.2x |
| Revenue | $21.00B(TTM) | $11.03B(TTM) |
| Revenue growth (YoY) | 19.9% | 20.5% |
| Net income | $3.67B(TTM) | $3.14B(TTM) |
| Earnings growth (YoY) | 56.7% | 23.0% |
| EPS, diluted | $2.47(TTM) | $8.72(TTM) |
| EBIT margin | 18.0% | 29.3% |
| ROE | 11.6% | 15.7% |
| ROIC | 10.0% | — |
| Piotroski F | 8/9 | — |
| 1y total return | -56.1% | -13.1% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: BSX frente a ISRG
| Métrica | BSX | ISRG |
|---|---|---|
| Valor final | $19.9K | $53.6K |
| Retorno total | +99.0% | +436.0% |
| CAGR | +6.9% | +17.6% |
| Volatilidad | 27.4% | 32.7% |
| Sharpe | 0.23 | 0.54 |
| Sortino | 0.31 | 0.77 |
| Caída máxima | -60.6% | -49.9% |
Basado en 2600 días de negociación comunes, 2016-05-12 → 2026-09-15 · tasa libre de riesgo 4.11% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)